WiseGuyReports

Global Tissue Paper Market Share, Supply, Analysis and Forecast to 2025

A new market study, titled “2019 Global and Regional Tissue Paper Market Research Report Forecast 2025”, has been featured on WiseGuyReports.

 

Pune, Maharashtra -- (SBWIRE) -- 12/06/2019 -- Report Overview:

The human body serves as a host to a networked community of microbiome that outnumbers the body's cells. The microbiome comprises all of the genetic material within a microbiota that is equivalent to the entire collection of microorganisms in a specific niche, such as the human gut or oral cavity. The interaction between the human microbiome and immune system affects several human metabolic functions and impacts well-being. Microbiome is a viable alternative for disease research, providing a more detailed analysis of the species present in the microbiome. The study of the human microbiome is done to determine the role of these microbes in human health and diseases caused as the microbes present may be pathogenic or beneficial.

The global human microbiome market size was worth $ 461 million in 2018 and is forecasted to reach $ 1,380 million by 2026, at a CAGR of 17.8% during the forecast period (2019-2026).

Request Free Sample Report at: https://www.wiseguyreports.com/sample-request/4532930-global-human-microbiome-market-2019-2026

Human Microbiome Market Dynamics
The human microbiome market growth is driven by several factors, such as massive investment in microbiome research, an increase in government funding and technological advancements.
Microbiome is attracting a lot of investment from the government as well as prominent private organizations. There are various companies and startups that are working in the field which accounts for a total of around 120. According to a report published by the Wall Street Journal, the investment in microbiome firms has increased from 2011 to 2015 by about 500%. The increase in investment and funding is due to the awareness of the uses and harms of the microbiome and how they affect the human body. Such discoveries can lead to breakthroughs in many human disease's treatments. For instance, uBiome, a company working in the microbiome segment, is developing genomic tests meant to identify and diagnose harmful microbes in the body. One of the applications of microbiome is personalized medicine, Human Longevity Inc., is putting $220 million into the of microbiome DNA to uncover disease-associated imbalances in microbial populations. This latter case is aimed at the development of personalized medicines for patients with different conditions.

View Detailed, Report at : https://www.wiseguyreports.com/reports/4532930-global-human-microbiome-market-2019-2026

Global Human Microbiome Market By Product:
- Shotgun
- Targeted Gene
- RNA
- Whole-genome
- Others

Among these shotgun is expected to hold a dominant market share over the period of forecast (2019-2026) due to faster process than other methods. Shotgun involves randomly breaking up DNA sequences into lots of small pieces and then reassembling the sequence by looking for regions of overlap. Shotgun is particularly efficient if there is an existing reference sequence. It is much easier to assemble the genome sequence by aligning it to an existing reference genome. Shotgun is much faster and less expensive than other methods that require a genetic map.

Global Human Microbiome Market By Technology:
- Ligation
- Pyro
- Sanger
- Others

Global Human Microbiome Market By Application:
- Therapeutics
- Genetic screening
- Drug discovery
- Biomarker discovery
- Personalized medicines
- Others

We also can offer customized report to fulfill special requirements of our clients. Regional and Countries report can be provided as well.

About Wise Guy Reports
Wise Guy Reports are a part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the global.

Contact Us:

NORAH TRENT

sales@wiseguyreports.com

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)